Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Cancer Research
|
July 31, 2024
A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants
Yan Yang, Avvaru N Suhasini, Zaoli Jiang, et al.
Molecular Cancer Therapeutics
|
March 18, 2014
ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models
Li Zhang, Carla Castanaro, Bo Luan, et al.
Plos One
|
January 4, 2017
Correction: Managing Climate Change Refugia for Climate Adaptation
Toni Lyn Morelli, Christopher Daly, Solomon Z Dobrowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2019
A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models
John O DaSilva, Katie Yang, Andres E Perez Bay, et al.
Plos One
|
August 11, 2016
Managing Climate Change Refugia for Climate Adaptation
Toni Lyn Morelli, Christopher Daly, Solomon Z Dobrowski, et al.
Science Advances
|
April 14, 2023
IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models
Marisa Carbonaro, Kehui Wang, Hui Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2011
Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor
Keith D Anderson, Li Pan, Xiao-man Yang, et al.
Molecular Cancer Therapeutics
|
July 28, 2021
A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade
John O DaSilva, Katie Yang, Oliver Surriga, et al.
Plos One
|
July 29, 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
Linda J Bristow, Amy E Easton, Yu-Wen Li, et al.
Science Translational Medicine
|
June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
Janelle C Waite, Bei Wang, Lauric Haber, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Cancer Research
|
July 31, 2024
A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants
Yan Yang, Avvaru N Suhasini, Zaoli Jiang, et al.
Molecular Cancer Therapeutics
|
March 18, 2014
ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models
Li Zhang, Carla Castanaro, Bo Luan, et al.
Plos One
|
January 4, 2017
Correction: Managing Climate Change Refugia for Climate Adaptation
Toni Lyn Morelli, Christopher Daly, Solomon Z Dobrowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2019
A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models
John O DaSilva, Katie Yang, Andres E Perez Bay, et al.
Plos One
|
August 11, 2016
Managing Climate Change Refugia for Climate Adaptation
Toni Lyn Morelli, Christopher Daly, Solomon Z Dobrowski, et al.
Science Advances
|
April 14, 2023
IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models
Marisa Carbonaro, Kehui Wang, Hui Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2011
Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor
Keith D Anderson, Li Pan, Xiao-man Yang, et al.
Molecular Cancer Therapeutics
|
July 28, 2021
A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade
John O DaSilva, Katie Yang, Oliver Surriga, et al.
Plos One
|
July 29, 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
Linda J Bristow, Amy E Easton, Yu-Wen Li, et al.
Science Translational Medicine
|
June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
Janelle C Waite, Bei Wang, Lauric Haber, et al.
Page
of 5